Posted in | News | MEMS - NEMS

Micralyne to Develop MEMS-based Fiber-Optic Subsystems with Adamant-Kogyo

Micralyne, Inc., an independent MEMS developer-manufacturer specializing in high-value applications, today announced a collaboration with Adamant-Kogyo Co., Ltd., a leading supplier of fine precision products for the optical communications industry, for the development and manufacture of Micro-Electro-Mechanical Systems (MEMS)-based fiber-optic subsystems.

Left to Right: Mike Ciprick, Acting CEO, Micralyne; Yoichi Shimoda, President, Adamant

The companies’ joint solutions will serve markets for which a high-performance, ultra-reliable sensor-enabled communications backbone is essential.

Building upon a decade-long partnership in the global MEMS industry, Micralyne and Adamant will leverage their respective core competencies to develop new MEMS-based optical subsystems.

“Micralyne’s strength in optical MEMS component integration in performance-intensive industrial applications complements the subsystem design and packaging expertise of our longstanding partner, Adamant,” said Mike Ciprick, acting president and CEO, Micralyne. “Through our new alliance with Adamant, we aim to lead the industry in quality and reliability for the wide range of applications that benefit from MEMS-based fiber-optic sensors.”

“The global market for fiber-optic point sensors and related subsystems is growing exponentially,” said Yoichi Shimoda, president, Adamant. “In fact, the market research firm, ElectroniCast, has forecast a compound annual growth rate of more than 20% between 2012-2017, reaching US$3.98 billion by 2017. With demand for high-performance MEMS sensors especially strong—and with Micralyne so proficient there—we will work in partnership to map out the best possible solutions for this market.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.